Skip to main content

Journals in Bioorganic chemistry

    • Bioorganic & Medicinal Chemistry Letters

      • ISSN: 0960-894X
      BMCL (Bioorganic & Medicinal Chemistry Letters) publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with concise review articles and perspectives. BMCL publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of BMCL is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. BMCL continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials.BMCL welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targetsThe reporting of the discovery, design or optimization of potent new compounds or biological agentsthe analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental datathe reporting of "first-in-class" new therapeutic compoundsthe chemical biology or bioorganic/bioinorga... chemistry that significantly advances knowledge of a biological mechanismmethodologi... advances that are chemistry-based and which significantly impact on medicine or biologythe preparation and examination of biotherapeutics for the treatment of pathophysiological disease statesthe development of materials for specific therapeutic targetingManuscripts on phytochemistry, theoretical molecular dynamics and exclusively computational papers are out of scope. All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
    • Bioorganic & Medicinal Chemistry

      • ISSN: 0968-0896
      The Tetrahedron Journal for Research at the Interface of Chemistry and BiologyBioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents.The Journal welcomes papers on:the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targetsthe reporting of the discovery, design or optimization of potent new compounds or biological agentsthe analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental datathe reporting of "first-in-class" new therapeutic compoundsthe chemical biology or bioorganic/bioinorga... chemistry that significantly advances knowledge of a biological mechanismmethodologi... advances that are chemistry-based and which significantly impact on medicine or biologythe preparation and examination of biotherapeutics for the treatment of pathophysiological disease statesthe development of materials for specific therapeutic targetingAll manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
    • Cell Chemical Biology

      • ISSN: 2451-9456
      Cell Chemical Biology (originally Chemistry & Biology) is a Cell Press journal that aims to publish and promote the most important advances in chemical biology with integrity, responsiveness, fairness, and friendliness. Chemical biology is a multidisciplinary discipline that harnesses chemical principles to discover the molecular mechanisms of biological function and disease etiology and develop solutions for life sciences, biotechnology, and human health.Cell Chemical Biology encourages submission of basic, translational, and clinical research articles that provide significant conceptual advancements of broad general interest to researchers within the biological sciences, the biomedical sciences, and associated fields. Research areas that we consider within our scope include but are not limited to cancer biology, immunology, cell biology, microbiology, virology, RNA biology, synthetic biology, protein engineering, genome editing, drug discovery, metabolism, and physiology.We are interested in papers that report molecular mechanisms underlying cellular processes or disease biology, those that report new therapeutics derived from utilizing chemical biology tools, and those that report technologies that perturb, visualize, or measure biological processes. Examples of chemical or molecular tools include but are not confined to nucleic acids and/or their modifications, small molecules, antibodies, biologics, probes, engineered proteins, metabolites, lipids, sugars, and post-translational modifications.We also welcome submissions reporting significant technical advancements in molecular probes, sensors, tools, and technologies, including a proof-of-principle demonstration that the new methodology/tool will help address important questions in biomedical research that are of interest to our broad readership (from basic scientists to clinicians).For further clarifications or questions about our aims and scope, please feel welcome to contact us at [email protected] or email editors directly. You can also submit your manuscript as a presubmission inquiry.Visit the Cell Press website for more information about Cell Chemical Biology - http://www.cell.com/...
    • Tetrahedron Letters

      • ISSN: 0040-4039
      The Tetrahedron Family of journals are the home for organic chemists across disciplines and around the globe. We are building on a legacy of publishing excellence and offering dedicated editorial support and expert peer review; the choice to publish your work as open access or subscription; multiple article types; speed to publication; and unparalleled reach and visibility.TETL (Tetrahedron Letters) welcomes researchers from academia and industry and publishes the following article types: short communications, concise review articles and perspectives.Our scope is focused on but not limited to the following core topics: Catalysis in the broadest sense including: Asymmetric Catalysis, Biocatalysis, Photocatalysis and Electrocatalysis.Gre... & sustainable approaches to synthesisOrganic & Organometallic chemistry including synthetic methodologyChemical Biology and Bioorganic ChemistryNatural product synthesisSynthesis for drug discoveryAI and machine learning for synthesisFunctional organic and polymeric materialsSupramolecu... and macromolecular chemistry
    • Tetrahedron

      • ISSN: 0040-4020
      The Tetrahedron Family of journals are the home for organic chemists across disciplines and around the globe. We are building on a legacy of publishing excellence and offering dedicated editorial support and expert peer review; the choice to publish your work as open access or subscription; multiple article types; speed to publication; and unparalleled reach and visibility.Tetrahedr... welcomes researchers from academia and industry and publishes the following article types: full length research articles, reviews and perspectives.Our scope is focused on but not limited to the following core topics:Catalysis in the broadest sense including: Asymmetric Catalysis, Biocatalysis, Photocatalysis and Electrocatalysis.Gre... & sustainable approaches to synthesisOrganic & Organometallic chemistry including synthetic methodologyChemical Biology and Bioorganic ChemistryNatural product synthesisSynthesis for drug discoveryAI and machine learning for synthesisFunctional organic and polymeric materialsSupramolecu... and macromolecular chemistry
    • Bioorganic Chemistry

      • ISSN: 0045-2068
      Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.